Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6610 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2024-06-26 (argoviatoday.ch)
Luterbach: Man is fatally injured in an industrial accident at the Biogen factory
A man was fatally injured in an industrial accident at an industrial plant in Luterbach on Monday afternoon. An investigation was launched to clarify what happened.
Read more
2023-08-09 (endpts.com)
Denali, Takeda scrap PhI Alzheimer's drug due to safety signals, 'rapidly evolving' landscape
As Biogen takes a preclinical Denali compound targeting amyloid beta forward in Alzheimer’s, Denali is shelving another Alzheimer’s candidate that is partnered with Takeda and hits a different target.
Read more
2017-07-10 (fiercepharma.com)
Biogen, AbbVie hit with Zinbryta safety action in EU as MS market heats up
Biogen and AbbVie’s new multiple sclerosis drug Zinbryta faces fresh prescribing restrictions in Europe after regulators there reviewed liver injuries and one death in patients taking the drug. | Biogen and AbbVie’ s multiple sclerosis drug Zinbryta faces new prescribing restrictions in Europe after
Read more